Facebook Pixel Code
About Sickkids
About SickKids

Jonathan Wasserman, MD PhD

The Hospital for Sick Children
Staff Physician

Research Institute
Project Investigator
Genetics & Genome Biology

University of Toronto
Associate Professor

Phone: 416 813 7654 ext 228186
Fax: 416 813 6304
Email: jonathan.wasserman@sickkids.ca
Alternate Contact: Megan Imbrasas
Alternate Email: megan.imbrasas@sickkids.ca

Brief Biography

Dr. Jonathan Wasserman joined the endocrine staff at SickKids in July 2012 after completing a clinical and research fellowship in the division.  He undertook his medical training at Harvard Medical School and the Massachusetts Institute of Technology and subsequently pursued an internship and residency in paediatrics at Children’s Hospital Boston where he also served as a General Paediatric Hospitalist. He previously earned a PhD and completed post-doctoral training in genetics at the University of Cambridge, England.

Clinical Interests

  • Care of children with endocrine malignancies including thyroid and adrenal carcinoma and neuroendocrine tumours
  • Cancer genetics with a focus on hereditary cancer syndromes with endocrine manifestations
  • Endocrine surveillance and treatment for survivors of childhood cancer
  • Care of children with general endocrine disorders and diabetes mellitus

Research Interests

  • Genetics and genomics of paediatric papillary thyroid carcinoma
  • Health-care utilization patterns among young patients with thyroid carcinoma at diagnosis and during follow-up
  • Identification of prediction models to improve assessment of thyroid nodules in children and to gauge malignant potential
  • Optimization of transition to adult care and long-term surveillance

Research Activities

Dr. Wasserman’s research focuses primarily on paediatric thyroid cancer and spans both clinical and translational domains. Thyroid carcinoma is the most common endocrine malignancy and is the most common cancer in adolescent and young women in Canada. Although frequently more extensive and aggressive than thyroid cancer in older adults, paediatric and adolescent thyroid carcinoma is generally associated with excellent prognosis. Our research aims to identify the biological underpinnings of this behaviour and to identify improved treatment and follow-up paradigms for paediatric and adolescent patients with thyroid malignancies. We are using a number of research modalities to explore this including both genomic approaches as well as population-level databases.


For a list of Dr. Wasserman's publications please visit PubMed.